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Background
Cardiac magnetic resonance imaging (CMR) is the gold
standard for quantification of global and regional myocar-
dial function and is able to detect subclinical myocardial
dysfunction in the setting of a wide variety of myocardial
disease processes, including anthracycline induced cardio-
myopathy (AIC). Preliminary studies using T2-weighted
sequences have demonstrated increase in signal intensity
suggestive of myocardial edema during cancer therapy.
We hypothesized that reductions in mid-wall peak cir-
cumferential (εcc) and longitudinal (ειι) strain magnitude
and increase in T2 relaxation suggestive of myocardial
edema would precede changes in EF in a cohort of pedia-
tric patients newly diagnosed with cancer studied at base-
line and after 24-48 hours at set intervals of anthracycline
cumulative dose up to maximal therapy.
Methods
Twenty subjects aged 10-22 years, diagnosed with cancer
that required anthracycline therapy, were identified
and prospectively enrolled between January 2013 and
November 2014. Seven subjects withdrew and 43 visits
were completed for the remaining 13 subjects. All subjects
underwent CMR with routine cine acquisition, tissue char-
acterization, left ventricular ejection fraction (EF) and
strain analysis using a modified 16-segment model.
Results
Patients in the high dose group demonstrated an increase
in LV end-systolic volume index (ESVI) with progressive
decline in ejection fraction (EF), and strain magnitude
overtime (Figure 1 a-d). Decline in ειι (−17.2 ± 1.0)
occurred at lower cumulative doses (200-250 mg/m2) fol-
lowed by a decline in εcc (−17.82 ± 2.6) at 275-325 mg/m2
and EF < 55% at doses >375 mg/m2. No significant
increase in T2 relaxation or late gadolinium enhancement
(LGE) was present in any of the study subjects. Among
the low dose group there were similar changes up to maxi-
mal cumulative dose of 200 mg/m2 (Figure 2 a-d). Subjects
in the low dose group with the lowest ειι at baseline
attained the lowest EF in follow-up.
Conclusions
Asymptomatic pediatric patients exposed to high dose
anthracycline therapy developed abnormal strain para-
meters at lower cumulative doses, with a decline in ειι
occurring earliest, when compared to changes in EF. With
the exception of one high dose patient an increase in myo-
cardial T2 relaxation or positive LGE were not observed
acutely after anthracycline therapy. The excellent reprodu-
cibility for LVEF and early decline in strain magnitude by
CMR may help identify patients at high risk for develop-
ment of AIC and guide therapy to prevent or decrease the
incidence of late cardiac events.
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